Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK500668PMID: 29999727
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 118292-40-3
Drug Levels and Effects
Summary of Use during Lactation
Topical tazarotene has not been studied during breastfeeding. Some experts feel it should not be used on greater than 20% of the body surface area while nursing because of possible absorption.[1] If tazarotene is used, ensure that the infant's skin does not come into direct contact with the areas of maternal skin that have been treated and the infant does not ingest the product from the mother's skin.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Psoriasis) Adalimumab, Etanercept, Infliximab, Phototherapy, Tretinoin
References
- 1.
- Butler DC, Heller MM, Murase JE. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation. J Am Acad Dermatol. 2014;70:417.e1–10. [PubMed: 24528912]
Substance Identification
Substance Name
Tazarotene
CAS Registry Number
118292-40-3
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Adapalene.[Drugs and Lactation Database (...]Review Adapalene.. Drugs and Lactation Database (LactMed®). 2006
- Review Prednicarbate.[Drugs and Lactation Database (...]Review Prednicarbate.. Drugs and Lactation Database (LactMed®). 2006
- Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin.[J Invest Dermatol. 1997]Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin.Nagpal S, Patel S, Jacobe H, DiSepio D, Ghosn C, Malhotra M, Teng M, Duvic M, Chandraratna RA. J Invest Dermatol. 1997 Jul; 109(1):91-5.
- Review Econazole.[Drugs and Lactation Database (...]Review Econazole.. Drugs and Lactation Database (LactMed®). 2006
- Review Sulconazole.[Drugs and Lactation Database (...]Review Sulconazole.. Drugs and Lactation Database (LactMed®). 2006
- Tazarotene - Drugs and Lactation Database (LactMed®)Tazarotene - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...